No Detail Found!

Individualized Management of Papillary Thyroid Microcarcinoma: Clinicopathological Risk Factors, Multifocality and Active Surveillance

Author(s)
Hayfa Abdullah Al-Olayan Department of Surgery, Collage of Medicine, Qassim University, Qassim, Kingdom of Saudia Arabia
Abstract
Objectives: Papillary Thyroid Microcarcinoma (PTMC), defined as papillary thyroid carcinoma =1 cm, accounts for an increasing share of thyroid cancer diagnoses worldwide. Although generally indolent, a subset exhibits aggressive clinicopathological features, including multifocality, extrathyroidal extension and lymph node metastasis, which complicate risk stratification and treatment. To summarize the current evidence regarding the prognostic significance of multifocality in PTMC, its underlying pathogenetic mechanisms and the evolving role of Active Surveillance (AS) versus surgical management. Methods: This narrative review integrates epidemiological, molecular, guideline and outcome data to outline a risk-adapted approach. Evidence was identified through a non-systematic literature search and no formal systematic-review or quantitative synthesis methodology was applied; findings should therefore be interpreted in this context. Institutional review board approval and informed consent were not required for this review of previously published literature. Results: Multifocality occurs in 2036% of papillary thyroid carcinomas and may arise from independent multicentric tumorigenesis or intrathyroidal clonal spread. Observational evidence has associated multifocality with an increased risk of recurrence in some, though not all, studies, particularly when combined with tumor size =6 mm, nodal involvement, or aggressive histologic variants; its independent effect on disease-specific mortality is less certain. Although AS is endorsed for selected low-risk PTMC, eligibility criteria vary internationally, especially for multifocal disease. The extent of surgery remains individualized. Conclusion: PTMC management should follow a risk-adapted strategy that integrates tumor focality, pathological features and patient factors to avoid overtreatment and undertreatment.
Publication Details
Page(s) 132-137
Published Journal: Journal of Pioneering Medical Sciences, Volume: 15, Issue: 6, Year: 2026

Request the full text from PASTIC

Keywords
Molecular Pathogenesis, Risk Stratification, Recurrence, Active surveillance, Thyroidectomy, Multifocality, Papillary Thyroid Microcarcinoma
References
Sung H. .2020 .GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries." CA: A Cancer Journal for Clinicians. "Global cancer statistics, 71(2021) : 209-249.
Yun M. . ."Visually discernible 18F-fluorodeoxyglucose uptake in papillary thyroid microcarcinoma: A potential new risk factor. " Journal of Clinical Endocrinology and Metabolism, 2626(2010) : 3182-3188.
Lin K.L. .2010 ."The BRAF mutation is predictive of aggressive clinicopathological characteristics in papillary thyroid microcarcinoma. " Annals of Surgical Oncology, 17(12) : 3294-3300.
El-Hag I.A.,Tallab R. .2025 ."Papillary thyroid carcinoma measuring 1.0 cm or less: An epidemiological and clinicopathological study." Frontiers in Oncology. , 1678065 : .
Lu Z. . ."Clonality analysis of multifocal papillary thyroid carcinoma using genetic profiles. " Journal of Pathology, 239(2016) : 72-83.
Pakdaman M.N. .2008 ."Incidence and histopathological behavior of papillary microcarcinomas: Study of 429 cases." Otolaryngology-Head and Neck Surgery. , 08(2008) : 718-722.
Chow S.M. . ."Papillary microcarcinoma of the thyroid: Prognostic significance of lymph node metastasis and multifocality. " Cancer, 98(2003) : 31-40.
Iida F.,Miyakawa M. . .:AID-CNCR2820240418>3.0. " Cancer, 24(196910) : 2-0142.
Katoh R.,: AID- R.,Z. R. . .CNCR2820700623>3.0. " Cancer, 70(19920915) : 1585-0142.
Shattuck T.M. .2005 ."Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma. " New England Journal of Medicine, 352(23) : 2406-2412.
McCarthy R.P. . ."Molecular evidence for the same clonal origin of multifocal papillary thyroid carcinomas. " Clinical Cancer Research, 05(2006) : 1078-0432.
Muzza M. " . .The clonal origin of multifocal papillary thyroid cancer: Intrathyroidal spread or independent tumors?". Minerva Endocrinology, 46(2021) : 03164-4.
Choi W.R. .2018 ."Multifocality of papillary thyroid carcinoma as a risk factor for disease recurrence. " Oral Oncology, 11 : 104-111.
Geron Y. .2018 ."Multifocality is not an independent prognostic factor in papillary thyroid cancer: A propensity score-matching analysis. " Thyroid, 0547(2019) : 513-522.
Joseph K.R. .2017 ."Multifocality as a prognostic factor in thyroid cancer: A meta-analysis.". International Journal of Surgery, 12 : 121-125.
Malandrino P. . ."Papillary thyroid microcarcinomas: A comparative study of the characteristics and risk factors at presentation in two cancer registries. " Journal of Clinical Endocrinology and Metabolism, 3728(2013) : 1427-1434.
Gür E.,Ö E. .2018 ."Multifocality-related factors in papillary thyroid carcinoma.". Asian Journal of Surgery, 12(2019) : 858-863.
Haugen B.R. .2015 ."2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. " Thyroid, 0020(2016) : 1-133.
Zhao J. .2025 ."Clinical prognostic risk assessment of different pathological subtypes of papillary thyroid cancer: A systematic review and network meta-analysis." Langenbeck's Archives of Surgery. , 410 : .
Sugitani I.,Fujimoto Y. . ."Symptomatic versus asymptomatic papillary thyroid microcarcinoma: A retrospective analysis of surgical outcome and prognostic factors.". Endocrine Journal, 46(1999) : 209-216.
Sugitani I. .2018 ."Active surveillance for very low-risk papillary thyroid carcinoma. " Annals of Thyroid, 11(2018) : 83-93.
Kim M.J. .1926 ."Active surveillance for low-risk thyroid cancers: A review of current practice guidelines." Endocrinology and Metabolism. , 39(2024) : 47-60.
So Y.K. .2015 ."Multifocality and bilaterality of papillary thyroid microcarcinoma." Clinical and Experimental Otorhinolaryngology. , 8(2015) : 174-178.
Omi Y. .2022 ."Pathological multifocality is not a prognostic factor of papillary thyroid carcinoma with non-total thyroidectomy.". World Journal of Surgical Oncology, 20 : .
0

Citations

0

Downloads

16

Views